Fenbufen

Fenbufen

SCHEMBL8199650

O=C(O)CCC(=O)c1ccc(-c2ccccc2)cc1.O=C(O)Cc1ccc(-c2ccccc2)cc1

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 3/20 0.80
SMN1; SMN2 Q16637 3/20 0.80
LMNA P02545 2/20 0.80
CYP1A2 P05177 1/20 0.80
RAB9A P51151 1/20 0.80
HIF1A Q16665 1/20 0.80
GAA P10253 2/20 0.70
ABCC4 O15439 1/20 0.70
TSHR P16473 1/20 0.70
PTGS1 P23219 1/20 0.70
HTT P42858 1/20 0.70
NR4A2 P43354 1/20 0.61
NR1H4 Q96RI1 2/20 0.59
L3MBTL1 Q9Y468 3/20 0.57
HPGD P15428 1/20 0.57
ALDH1A1 P00352 1/20 0.56
CYP2C19 P33261 1/20 0.56
SRD5A2 P31213 1/20 0.56
AKR1B1 P15121 1/20 0.52
PTPN1 P18031 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fenbufen SCHEMBL11329267 0.89 SMN1; SMN2 (1.00) FFAR1SMN1; SMN2LMNACYP1A2RAB9A
Fenbufen SCHEMBL25117 0.89 SMN1; SMN2 (1.00) FFAR1SMN1; SMN2LMNACYP1A2RAB9A
Fenbufen SCHEMBL11393779 0.88 SMN1; SMN2 (0.96) FFAR1SMN1; SMN2LMNACYP1A2RAB9A
Felbinac SCHEMBL28284677 0.86 LMNA (0.95) FFAR1SMN1; SMN2LMNACYP1A2RAB9A
SCHEMBL10884944 0.84 SMN1; SMN2 (0.88) FFAR1SMN1; SMN2LMNACYP1A2RAB9A
Felbinac SCHEMBL26084 0.84 LMNA (1.00) FFAR1LMNAGAAABCC4TSHR
Felbinac SCHEMBL8844919 0.82 LMNA (0.95) FFAR1LMNAGAAABCC4TSHR
Felbinac SCHEMBL384892 0.82 LMNA (0.95) FFAR1LMNAGAAABCC4TSHR
Felbinac SCHEMBL28284672 0.82 LMNA (0.95) FFAR1LMNAGAAABCC4TSHR
Felbinac SCHEMBL28286223 0.82 LMNA (0.95) FFAR1LMNAGAAABCC4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0759750-A4 COMPOSITIONS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES SHAPIRO HOWARD K (US) 1998-05-27 EP claimed
EP-0759750-A1 COMPOSITIONS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES SHAPIRO, Howard, K. (US) 1997-03-05 EP claimed
WO-1995031194-A1 COMPOSITIONS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES SHAPIRO HOWARD K (US) 1995-11-23 WO claimed
EP-0977725-A1 NEW FATTY ACID DERIVATIVES NORSK HYDRO ASA (NO) 2000-02-09 EP disclosed
WO-1998032718-A1 NEW FATTY ACID DERIVATIVES NORSK HYDRO ASA (NO) 1998-07-30 WO disclosed